Published in J Clin Oncol on December 01, 1994
Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas. Oncogene (2011) 1.66
Survival of pediatric patients after relapsed osteosarcoma: the St. Jude Children's Research Hospital experience. Cancer (2013) 1.32
Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors. Cancer (2008) 1.24
Current status and perspectives regarding the treatment of osteo-sarcoma: chemotherapy. Rev Recent Clin Trials (2008) 1.16
Inhaled granulocyte-macrophage colony stimulating factor for first pulmonary recurrence of osteosarcoma: effects on disease-free survival and immunomodulation. a report from the Children's Oncology Group. Clin Cancer Res (2010) 0.87
CD133 expression predicts lung metastasis and poor prognosis in osteosarcoma patients: A clinical and experimental study. Exp Ther Med (2012) 0.86
Comparison of pirarubicin-based versus gemcitabine-docetaxel chemotherapy for relapsed and refractory osteosarcoma: a single institution experience. Int J Clin Oncol (2012) 0.82
Stereotactic radiosurgery, a potential alternative treatment for pulmonary metastases from osteosarcoma. Int J Oncol (2014) 0.82
Patients with osteosarcoma with a single pulmonary nodule on computed tomography: a single-institution experience. J Pediatr Surg (2012) 0.80
Clinical characteristics and prognosis of osteosarcoma in young children: a retrospective series of 15 cases. BMC Cancer (2011) 0.80
Osteosarcoma Overview. Rheumatol Ther (2016) 0.79
What are the factors that affect survival and relapse after local recurrence of osteosarcoma? Clin Orthop Relat Res (2014) 0.79
The Current and Future Therapies for Human Osteosarcoma. Curr Cancer Ther Rev (2013) 0.79
MicroRNA-33a-5p suppresses growth of osteosarcoma cells and is downregulated in human osteosarcoma. Oncol Lett (2015) 0.78
Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7. Clin Exp Med (2015) 0.77
High Dose Thiotepa in Patients with Relapsed or Refractory Osteosarcomas: Experience of the SFCE Group. Sarcoma (2014) 0.77
Osteosarcoma relapse as pleural metastasis. South Asian J Cancer (2013) 0.77
miR‑542‑3p overexpression is associated with enhanced osteosarcoma cell proliferation and migration ability by targeting Van Gogh‑like 2. Mol Med Rep (2014) 0.76
Human Sarcoma growth is sensitive to small-molecule mediated AXIN stabilization. PLoS One (2014) 0.75
Metastatic osteosarcoma: a review of current issues in systemic treatment. Sarcoma (1997) 0.75
Comparison of pemetrexed plus cisplatin with gemcitabine plus docetaxel in refractory/metastatic osteosarcoma: Clinical outcomes from a retrospective database monitored in a single institute. Oncol Lett (2014) 0.75
Outcomes of Adolescent and Adult Patients with Lung Metastatic Osteosarcoma and Comparison of Synchronous and Metachronous Lung Metastatic Groups. PLoS One (2016) 0.75
Ifosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcoma. Br J Cancer (1999) 0.75
Downregulation of CD99 and upregulation of human leukocyte antigen class II promote tumor aggravation and poor survival in patients with osteosarcomas. Onco Targets Ther (2014) 0.75
Unusual abdominal metastases in osteosarcoma. J Pediatr Surg Case Rep (2018) 0.75
Poor prognosis infantile fibrosarcoma with pathologic features of malignant fibrous histiocytoma after local recurrence. Med Pediatr Oncol (1990) 2.67
P53 germline mutations in childhood cancers and cancer risk for carrier individuals. Br J Cancer (2000) 2.35
Results of the Sixth International Society of Pediatric Oncology Wilms' Tumor Trial and Study: a risk-adapted therapeutic approach in Wilms' tumor. J Clin Oncol (1993) 1.88
Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood. Lancet (1997) 1.84
Effect of hypothalamic and pituitary irradiation on pubertal development in children with cranial tumors. J Clin Endocrinol Metab (1982) 1.78
Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study. J Clin Oncol (2005) 1.70
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique. J Clin Oncol (1997) 1.59
Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells. Eur J Immunol (1978) 1.58
An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32). Eur J Cancer (2005) 1.54
An antigen shared by a human T cell subset and B cell chronic lymphocytic leukemic cells. Distribution on normal and malignant lymphoid cells. J Exp Med (1980) 1.50
Parameningeal rhabdomyosarcoma: results of an international workshop. Int J Radiat Oncol Biol Phys (1996) 1.50
Pancreatoblastoma: response to chemotherapy. Med Pediatr Oncol (1991) 1.49
High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol (1991) 1.49
High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: a phase II study. Bone Marrow Transplant (1992) 1.49
Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol (2001) 1.48
Dural sinus thrombosis in children with cancer. Med Pediatr Oncol (1997) 1.45
Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int J Radiat Oncol Biol Phys (1999) 1.40
Effectiveness of preoperative chemotherapy in Wilms' tumor: results of an International Society of Paediatric Oncology (SIOP) clinical trial. J Clin Oncol (1983) 1.39
Wilms' tumor: natural history and prognostic factors: a retrospective study of 248 cases treated at the Institut Gustave-Roussy 1952-1967. Cancer (1976) 1.39
Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification. Br J Cancer (2007) 1.39
Papillomas and carcinomas of the choroid plexus in children. J Neurosurg (1998) 1.34
Is there a place for radiation therapy in the management of hepatoblastomas and hepatocellular carcinomas in children? Int J Radiat Oncol Biol Phys (1992) 1.34
Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood. Int J Cancer (1998) 1.32
Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma. Ann Neurol (1999) 1.29
Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer (1990) 1.29
CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology. Blood (1998) 1.28
Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society. J Clin Oncol (1986) 1.26
Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma. J Clin Oncol (1996) 1.26
Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 patients treated in a single institution. Bone Marrow Transplant (1999) 1.23
Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84. Eur J Cancer (1998) 1.17
Presence of circulating antibodies against cellular protein p53 in a notable proportion of children with B-cell lymphoma. Int J Cancer (1987) 1.17
Choroid plexus carcinomas in childhood: clinical features and prognostic factors. Neurosurgery (1998) 1.17
Musculoskeletal tumors: follow-up with MR imaging after treatment with surgery and radiation therapy. Radiology (1987) 1.15
Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma. Br J Cancer (2011) 1.15
Thyroid carcinomas after irradiation for a first cancer during childhood. Arch Intern Med (2000) 1.13
Lymph node invasion and prognosis in nephroblastoma. Cancer (1980) 1.13
Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study. Cancer (2005) 1.12
Localized childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90. J Clin Oncol (2000) 1.11
Growth and endocrine disorders in optic glioma. Eur J Pediatr (1990) 1.11
Determinants of patient satisfaction in oncology settings from European and Asian countries: preliminary results based on the EORTC IN-PATSAT32 questionnaire. Eur J Cancer (2006) 1.10
Combined treatment modality for intracranial germinomas: results of a multicentre SFOP experience. Société Française d'Oncologie Pédiatrique. Br J Cancer (1999) 1.10
Correlation of MDR1 gene expression with chemotherapy in neuroblastoma. J Natl Cancer Inst (1989) 1.08
When do children with optic pathway tumours need treatment? An oncological perspective in 106 patients treated in a single centre. Eur J Pediatr (2000) 1.08
Intracranial Ewing sarcoma/'peripheral' primitive neuroectodermal tumor of dural origin with molecular genetic confirmation. J Neurooncol (2001) 1.08
Treatment of intracranial ependymomas of children: review of a 15-year experience. Int J Radiat Oncol Biol Phys (1994) 1.07
Effects of pulmonary function of whole lung irradiation for Wilm's tumour in children. Thorax (1982) 1.07
Human T cell differentiation antigens and correlation of their expression with various markers of T cell maturation. J Immunol (1979) 1.06
Screening for germ line p53 mutations in children with malignant tumors and a family history of cancer. Cancer Res (1993) 1.06
Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patients. J Clin Endocrinol Metab (1987) 1.05
Male gonadal function after chemotherapy for solid tumors in childhood. J Clin Oncol (1989) 1.04
Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors. Cancer Res (1980) 1.04
Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment. Br J Cancer (1999) 1.04
Subsets of malignant lymphomas in children related to the cell phenotype. Blood (1979) 1.03
Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas. Cancer (2000) 1.03
Prospective validation of a novel IV busulfan fixed dosing for paediatric patients to improve therapeutic AUC targeting without drug monitoring. Cancer Chemother Pharmacol (2007) 1.03
Pulmonary evaluation of patients with osteosarcoma: roles of standard radiography, tomography, CT, scintigraphy, and tomoscintigraphy. AJR Am J Roentgenol (1984) 1.01
How to establish equivalence when data are censored: a randomized trial of treatments for B non-Hodgkin lymphoma. Stat Med (1993) 1.01
Outcome of flat bone sarcomas (other than Ewing's) in children and adolescents: a study of 25 cases. Br J Cancer (2004) 1.01
Hemorrhagic cystitis following high-dose chemotherapy and bone marrow transplantation in children with malignancies: incidence, clinical course, and outcome. J Clin Oncol (1989) 1.01
Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure. Bone Marrow Transplant (1998) 1.00
Outcome of radiation-related osteosarcoma after treatment of childhood and adolescent cancer: a study of 23 cases. J Clin Oncol (1999) 0.99
Busulfan pharmacokinetics following intravenous and oral dosing regimens in children receiving high-dose myeloablative chemotherapy for high-risk neuroblastoma as part of the HR-NBL-1/SIOPEN trial. Eur J Cancer (2012) 0.99
Non-T, non-B lymphomas are rare in childhood and associated with cutaneous tumor. Blood (1982) 0.98
Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP study. Eur J Cancer (2006) 0.97
Serum alpha-1 foeto-protein (fetuin) in children with malignant ovarian or testicular teratomas. Preliminary results. Int J Cancer (1969) 0.97
Nonmetastatic intracranial germinoma: the experience of the French Society of Pediatric Oncology. Cancer (1997) 0.97
Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma. J Clin Oncol (1987) 0.97
Carboplatin before and during radiation therapy for the treatment of malignant brain stem tumours: a study by the Société Française d'Oncologie Pédiatrique. Eur J Cancer (2002) 0.96
Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children. Bone Marrow Transplant (1992) 0.96
Potent therapeutic activity of irinotecan (CPT-11) and its schedule dependency in medulloblastoma xenografts in nude mice. Int J Cancer (1997) 0.96
Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma? J Neurooncol (1996) 0.96
Dose-dependent neurotoxicity of high-dose busulfan in children: a clinical and pharmacological study. Cancer Res (1990) 0.96
Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN study. Eur J Cancer (2013) 0.95
Long-term follow up of 69 patients treated for optic pathway tumours before the chemotherapy era. Arch Dis Child (1998) 0.95
Rarity of surgical complications after postchemotherapy nephrectomy for nephroblastoma. Experience of the International Society of Paediatric Oncology-Trial and Study "SIOP-9". International Society of Paediatric Oncology Nephroblastoma Trial and Study Committee. Eur J Pediatr Surg (1998) 0.95
The radiological appearances of telangiectatic osteosarcoma. A study of 14 cases. Skeletal Radiol (1987) 0.95
Long-term risk of second malignant neoplasm after a cancer in childhood. Br J Cancer (1989) 0.95
Prognostic factors in pediatric spinal cord astrocytoma. Cancer (1998) 0.95
Ifosfamide and etoposide in childhood osteosarcoma. A phase II study of the French Society of Paediatric Oncology. Eur J Cancer (1997) 0.95
High-grade glioma in children under 5 years of age: a chemotherapy only approach with the BBSFOP protocol. Eur J Cancer (2006) 0.94
The role of radiation therapy in the management of craniopharyngioma: a 25-year experience and review of the literature. Int J Radiat Oncol Biol Phys (1999) 0.94
Wilm's tumor with pulmonary metastases at diagnosis: the significance of primary chemotherapy. International Society of Pediatric Oncology Nephroblastoma Trial and Study Committee. J Clin Oncol (1990) 0.94
[Neurofibromatosis 1: recommendations for management]. Arch Pediatr (2002) 0.94
Hypercalcemia preferentially occurs in unusual forms of childhood non-Hodgkin's lymphoma, rhabdomyosarcoma, and Wilms' tumor. A study of 11 cases. Cancer (1984) 0.94
Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma. Cancer Res (1991) 0.93
Pain in children aged 2-6 years: a new observational rating scale elaborated in a pediatric oncology unit--preliminary report. Pain (1987) 0.93